The American Academy of Ophthalmology (Academy) has collaborated with Cloud Nine Development, LLC, to enhance its free iPhone application, the Eye Handbook. The application, created for ophthalmologists by ophthalmologists, offers ophthalmic calculat…
Category: News
Reading Difficulties In Stroke Patients Commonly Caused By Eye Movement Problems
Visual problems can affect up to two thirds of stroke patients, but can sometimes go undetected if patients do not recognise them as an after-effect of the condition or if they are unable to communicate the problem to their medical team or families…
Over 100,000 Older People Have Sight Loss And Dementia
Chairing the first national “Dementia and Sight Loss conference” in London, Baroness Sally Greengross will announce that two per cent of people over 75 will have both conditions. They face double the burden when performing simple tasks like going to t…
Researchers Achieve Extensive Regeneration In Nerve Connecting Eye To Brain
Findings bring scientists closer to restoring vision loss due to optic nerve damage
Omega 3 Rich Foods Protect Seniors From Age-Related Macular Degeneration (AMD)
Seniors whose diets are rich in omega 3 fatty acids have a significantly lower risk of developing AMD (age-related macular degeneration) compared to other people of the same age, scientists revealed in the journal Ophthalmology. Good sources of Omega 3…
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: 1-year Outcomes of a Prospective, Double-masked Randomised Clinical Trial
This study compares two drugs in the treatment of age-related macular degeneration. Eye
New Test Detects Glaucoma While Reversible (CME/CE)
(MedPage Today) — A steady-state pattern electroretinogram known as PERGLA was able to detect destruction of retinal ganglion cells early enough to allow vision correcting surgery, a prospective study found.
Link Between Heart Disease And Air Pollution
By digitally photographing the tiny, hair-like blood vessels in the back of our eyes, researchers can now look directly at how small blood vessels like those that bring blood to the heart respond to air pollution…
Accumulated Doses of Irradiation to the Lens May be Cataractogenic
Irradiation toxic effects of intra-arterial chemotherapy
may be cataractogenic and possibly carcinogenic, especially
in irradiation-sensitive patients with retinoblastoma,
according to a study published in the Archives of
Ophthalmology.1
The prospectiv…
FAME: 24-month Readout Shows Steady Improvement
Vision continued to significantly improve at 2 years with
the fluocinolone acetonide intravitreal insert (Iluvien,
Alimera Sciences), according to Baruch D. Kuppermann,
MD, PhD, who presented the 24-month readout of the
FAME trial at the American Acade…
Carl Zeiss Introduces Multispot Photocoagulation Laser
Carl Zeiss Meditec, Inc. (Dublin, CA), introduced the
Visulas 532s Vite photocoagulator at the AAO in Chicago.
The device recently received marketing clearance from
the FDA. According to the company, the Visulas 532s Vite
photocoagulator features varia…
Ranibizumab Improved Visual Outcomes in DME
Patients with DME achieved better long-term visual
outcomes when treated with ranibizumab (Lucentis,
Genentech) and focal/grid laser combination therapy
than with ranibizumab or laser alone, according to the
results of the phase 2 READ-2 study publishe…
VEGF Trap-Eye Noninferior to Ranibizumab in Two Phase 3 Trials
In patients with wet age-related macular degeneration
(AMD), all regimens of aflibercept (VEGF Trap-
Eye, Regeneron), including aflibercept dosed every
2 months, achieved the primary endpoint compared
with ranibizumab (Lucentis, Genentech) dosed every
…
Pegaptanib Maintained Vision Gains at 2 Years
Pegaptanib sodium injection (Macugen, Eyetech, Inc.)
significantly improved vision in patients with DME and
maintained and expanded vision gains in patients over a
2-year period, according to phase 3 data presented by
Marla B. Sultan, MD, MBA, at the A…
Eyetech Awarded Grant for Extended-Release Formulation of Macugen
Eyetech Inc. (Palm Beach Gardens, FL) has been awarded
a $245,000 grant to support the development of an
extended-release formulation of pegaptanib sodium
injection (Macugen) using microparticles technology,
according to a company news release.
At the …
FDA Permits Stem Cell Clinical Trial for Stargardt to Begin
Advanced Cell Technology, Inc. (Santa Monica, CA), has
received clearance from the FDA to conduct a phase 2/3
clinical trial using retinal pigment epithelium (RPE) cells
derived from human embryonic stem cells to treat patients
with Stargardt macular d…
VisionCare’s AMD Telescope Wins Award
The Implantable Miniature Telescope (IMT; VisionCare
Ophthalmic Technologies, Inc., Saratoga, CA) was recently named “Best of What’s New” 2010 by Popular
Science magazine. Created by Isaac Lipshitz, MD, the
miniature device is designed to improve…
Canon’s CR-2 Digital Non- Mydriatic Retinal Camera Receives FDA Clearance
The Canon CR-2 Digital Non-Mydriatic Retinal Camera
(Canon USA, Inc., Lake Success, NY) has received 510(k)
clearance from the FDA. The CR-2 integrates the latest in
Canon’s retinal imaging technology and enhancements in
a compact frame and is the li…
Single Injection of Bevacizumab Effective in Eyes With Myopic Choroidal Neovascularization
One intravitreal injection of bevacizumab (Avastin,
Genentech) seems to be an effective therapeutic
approach to treat choroidal neovascularization in
highly myopic eyes, according to a study in Retina.1
José M. Ruiz-Moreno, MD, PhD, of the Instituto
O…
EyeGate to Develop Corticosteroid Solution for Retinal Disorders
EyeGate Pharma (Waltham, MA) announced that it
has received four federal grants totaling nearly $1 million
for programs that focus on the continued clinical development
of EGP-437, a corticosteroid solution administered by the EyeGate II delivery syste…